Related Experiment Video
Updated: May 22, 2026

23:06
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Multidrug-resistant tuberculosis that required 2 years for diagnosis
Shuichi Yano1, Kanako Kobayashi, Toshikazu Ikeda
1National Hospital Organization Matsue Medical Centre, Matsue, Japan. yano@matsue.hosp.go.jp
BMJ Case Reports
|May 19, 2012
Summary
Multidrug-resistant tuberculosis (MDRTB) diagnosis is challenging. This case highlights the difficulty in cultivating resistant Mycobacterium tuberculosis strains, even with specialized methods.
Area of Science:
- Microbiology
- Infectious Diseases
- Clinical Medicine
Background:
- Standard tuberculosis (TB) treatment relies on first-line drugs like isoniazid (H) and rifampicin (R).
- Mono-resistance to H or R is manageable with first-line agents.
- Multidrug-resistant tuberculosis (MDRTB) necessitates complex treatment regimens involving multiple drugs, including quinolones and injectables.
Observation:
- Drug-resistant Mycobacterium tuberculosis strains present significant in vitro cultivation challenges.
- A case of MDRTB experienced a diagnostic delay of two years.
- Detection of the resistant pathogen was ultimately achieved through sputum culture on solid medium.
Findings:
- The diagnosis of MDRTB was significantly prolonged due to difficulties in pathogen cultivation.
- Solid medium sputum culture proved essential for identifying the resistant Mycobacterium tuberculosis strain in this complex case.
Implications:
- Physicians must maintain a high index of suspicion for MDRTB in cases where TB is suspected but initial pathogen detection is negative.
- Delayed diagnosis of MDRTB can lead to prolonged patient suffering and potential disease transmission.
- Further research into improved diagnostic methods for drug-resistant tuberculosis is warranted.
Related Concept Videos
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...